Announcement of expected loss in performance for the first half of 2024.

Sensex a shareJul 9 12:00 ET · Announcements

Thalys Medical Technology Group Corporation (603716.SH): the SPD system has not yet applied the openai API interface temporarily.

On July 8th, Gelonghui reported that an investor asked Thalys Medical Technology Group Corporation (603716.SH) on an investor interaction platform whether the company's SPD system is using the openai API interface. The company replied that the SPD system of the company has not yet applied the openai API interface.

Gelonghui FinanceJul 8 06:06 ET

Thalys Medical Technology Group Corporation (603716.SH): Cumulative repurchase of 0.9476% of the company's shares.

Thalys Medical Technology Group Corporation (603716.SH) announced that by June 30, 2024, the company repurchased a total of 1,907,700 shares of the company through the Shanghai Securities Exchange trading system by centralized bidding. The repurchased shares accounted for 0.9476% of the company's total share capital, and the highest and lowest fill prices of the repurchases were 6.02 yuan/share and 5.54 yuan/share, respectively. The total amount paid was RMB 11,053,889 (excluding transaction costs).

Gelonghui FinanceJul 1 06:43 ET

Thalys Medical Technology Group Corporation (603716.SH): Repurchased 837,200 shares for the first time.

On June 5, Glon Hui reported that Thalys Medical Technology Group Corporation (603716.SH) announced that on June 5, 2024, the company completed the repurchase of 837,200 shares of stock for the first time by means of centralized bidding trading on the Shanghai Stock Exchange trading system, accounting for 0.4158% of the total equity of the company. The highest and lowest repurchase prices were 6.04 yuan per share and 5.99 yuan per share respectively, and the total amount paid for the repurchase was RMB 5,031,779 (excluding transaction fees).

Gelonghui FinanceJun 5 05:52 ET

Saili Healthcare (603716.SH): Net profit of 3.156,800 yuan in the first quarter

On April 27, Ge Longhui Medical (603716.SH) released its report for the first quarter of 2024, achieving operating income of 485 million yuan, an increase of 9.24% over the previous year; net profit attributable to shareholders of listed companies was 3.156,800 yuan, net profit attributable to shareholders of listed companies was 9097 million yuan after deducting non-recurring profit and loss, with basic earnings of 0.02 yuan per share.

Gelonghui FinanceApr 26 22:21 ET

Saili Healthcare (603716.SH) announced first-quarter results, net profit of 3.156,800 yuan

According to the Zhitong Finance App, Saili Healthcare (603716.SH) released its report for the first quarter of 2024. During the reporting period, the company achieved operating income of 485 million yuan, an increase of 9.24% over the previous year; net profit attributable to shareholders of listed companies was 3.156,800 yuan; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 9097 million yuan; and basic earnings per share were 0.02 yuan.

Zhitong FinanceApr 26 13:01 ET